113 related articles for article (PubMed ID: 8435338)
1. Characterization of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis.
Reilly JT; Barnett D; Dolan G; Forrest P; Eastham J; Smith A
Br J Haematol; 1993 Jan; 83(1):58-62. PubMed ID: 8435338
[TBL] [Abstract][Full Text] [Related]
2. A new fibroblast growth stimulating activity from the human megakaryoblastic leukaemia cell line ELF-153: in vitro and in vivo findings.
Hassan HT; Hanauske AR; Lux E; Kleine HD; Freund M
Int J Exp Pathol; 1995 Oct; 76(5):361-7. PubMed ID: 7488550
[TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of platelet-derived growth factor, transforming growth factor-beta, and fibronectin in acute megakaryoblastic leukemia manifesting tumor formation.
Kitagawa M; Yoshida S; Ishige I; Minami J; Kuwata T; Tanizawa T; Kamiyama R
Hum Pathol; 1994 Jul; 25(7):723-6. PubMed ID: 8026832
[TBL] [Abstract][Full Text] [Related]
4. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.
Martyré MC; Magdelenat H; Bryckaert MC; Laine-Bidron C; Calvo F
Br J Haematol; 1991 Jan; 77(1):80-6. PubMed ID: 1998600
[TBL] [Abstract][Full Text] [Related]
5. Myelofibrosis and acute megakaryoblastic leukemia in a child: topographic relationship between fibroblasts and megakaryocytes with an alpha-granule defect.
Breton-Gorius J; Bizet M; Reyes F; Dupuy E; Mear C; Vannier JP; Tron P
Leuk Res; 1982; 6(1):97-110. PubMed ID: 6461801
[TBL] [Abstract][Full Text] [Related]
6. Serum procollagen-III-peptide level correlates with disease activity in myelofibrosis with myeloid metaplasia.
Barosi G; Costa A; Liberato LN; Polino G; Spriano P; Magrini U
Br J Haematol; 1989 May; 72(1):16-20. PubMed ID: 2736239
[TBL] [Abstract][Full Text] [Related]
7. [TGF-beta and platelet].
Kogawa K; Mogi Y; Morii K; Takimoto R; Niitsu Y
Rinsho Ketsueki; 1994 Apr; 35(4):370-5. PubMed ID: 8028182
[TBL] [Abstract][Full Text] [Related]
8. [Beta-thromboglobulin and platelet factor 4 in a follow-up of acute myelofibrosis (megakaryoblastic leukemia)].
Palomera Bernal L; García Díez I
Med Clin (Barc); 1990 Jun; 95(1):21-4. PubMed ID: 2146451
[TBL] [Abstract][Full Text] [Related]
9. Megakaryoblastic termination of myeloproliferative disorders.
Amin MB; Maeda K; Carey JL; Babu RV; Raman BK
Henry Ford Hosp Med J; 1992; 40(1-2):122-6. PubMed ID: 1428963
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis.
Martyré MC; Romquin N; Le Bousse-Kerdiles MC; Chevillard S; Benyahia B; Dupriez B; Demory JL; Bauters F
Br J Haematol; 1994 Sep; 88(1):9-16. PubMed ID: 7803262
[TBL] [Abstract][Full Text] [Related]
11. Carboxy-terminal fragment of osteogenic growth peptide in vitro increases bone marrow cell density in idiopathic myelofibrosis.
Fazzi R; Pacini S; Testi R; Azzarà A; Galimberti S; Testi C; Trombi L; Metelli MR; Petrini M
Br J Haematol; 2003 Apr; 121(1):76-85. PubMed ID: 12670334
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
13. Micromegakaryocytic transformation of myelofibrosis with myeloid metaplasia.
Rosangela I; Pecci A; Formisano R
Haematologica; 2000 Jan; 85(1):98-9. PubMed ID: 10629600
[No Abstract] [Full Text] [Related]
14. Megakaryoblastic transformation of myelofibrosis with expression of the c-sis oncogene.
Marcus RE; Hibbin JA; Matutes E; Whittle N; Waterfield MD; Goldman JM
Scand J Haematol; 1986 Feb; 36(2):186-93. PubMed ID: 2422734
[TBL] [Abstract][Full Text] [Related]
15. Acute myelofibrosis in children: report on two cases.
Maj JS; Rosłan K; Fic-Sikorska B
Acta Haematol Pol; 1996; 27(1):79-84. PubMed ID: 8629448
[TBL] [Abstract][Full Text] [Related]
16. The role of transforming growth factor-beta in PEG-rHuMGDF-induced reversible myelofibrosis in rats.
Yanagida M; Ide Y; Imai A; Toriyama M; Aoki T; Harada K; Izumi H; Uzumaki H; Kusaka M; Tokiwa T
Br J Haematol; 1997 Dec; 99(4):739-45. PubMed ID: 9432016
[TBL] [Abstract][Full Text] [Related]
17. Refractory anemia terminating in acute megakaryoblastic leukemia (M7).
Adachi M; Ryo R; Yoshida A; Yamaguchi N; Izumi Y
Acta Haematol; 1989; 81(2):104-8. PubMed ID: 2496548
[TBL] [Abstract][Full Text] [Related]
18. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis.
Terui T; Niitsu Y; Mahara K; Fujisaki Y; Urushizaki Y; Mogi Y; Kohgo Y; Watanabe N; Ogura M; Saito H
Blood; 1990 Apr; 75(7):1540-8. PubMed ID: 2317561
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
[TBL] [Abstract][Full Text] [Related]
20. Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia.
Kimura A; Katoh O; Hyodo H; Kuramoto A; Satow Y
Leuk Lymphoma; 1995 Jul; 18(3-4):237-42. PubMed ID: 8535188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
